Info@ThinkPinkRocks.org

A reduced dose of alteplase has failed to prove itself noninferior to the standard dose in a predominantly Asian population of patients with ischaemic stroke.

View original post here:
ENCHANTED results challenge reduced alteplase dose in Asian stroke patients

Scroll to Top